Dr James David Mumper, MD | |
7229 Forest Ave, Suite 112, Richmond, VA 23226-3765 | |
(804) 282-2655 | |
(804) 282-1793 |
Full Name | Dr James David Mumper |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 41 Years |
Location | 7229 Forest Ave, Richmond, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518919653 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0101036866 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Henrico Doctors' Hospital | Richmond, VA | Hospital |
Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Partner Md Pc | 8022002617 | 24 |
News Archive
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
A certain cytokine, or small protein that helps cells communicate during immune responses, can control whether immune cells promote or suppress inflammatory bowel disease, a finding that could lead to new treatments, according to a study led by Georgia State University.
Seniors with giant cell arteritis – a chronic inflammatory condition of medium and large arteries – are twice as likely to have a heart attack or stroke compared to adults without this condition, says new University of Toronto research.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
PHT Corporation announced today the availability of the electronic version of the DHP-18 (Diabetes Health Profile) Quality of Life (QoL) questionnaire on all of its electronic patient reported outcome (ePRO) collection modalities - smartphone, tablet and Web. PHT is the global pacesetter in PRO and ePRO solutions that maximize the collection of high-quality data from clinical trial patients to improve clinical trial efficiencies.
› Verified 9 days ago
Entity Name | Partner Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255409371 PECOS PAC ID: 8022002617 Enrollment ID: O20040417000601 |
News Archive
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
A certain cytokine, or small protein that helps cells communicate during immune responses, can control whether immune cells promote or suppress inflammatory bowel disease, a finding that could lead to new treatments, according to a study led by Georgia State University.
Seniors with giant cell arteritis – a chronic inflammatory condition of medium and large arteries – are twice as likely to have a heart attack or stroke compared to adults without this condition, says new University of Toronto research.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
PHT Corporation announced today the availability of the electronic version of the DHP-18 (Diabetes Health Profile) Quality of Life (QoL) questionnaire on all of its electronic patient reported outcome (ePRO) collection modalities - smartphone, tablet and Web. PHT is the global pacesetter in PRO and ePRO solutions that maximize the collection of high-quality data from clinical trial patients to improve clinical trial efficiencies.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James David Mumper, MD 7001 Forest Ave, Suite 302, Richmond, VA 23230-1726 Ph: (804) 282-2655 | Dr James David Mumper, MD 7229 Forest Ave, Suite 112, Richmond, VA 23226-3765 Ph: (804) 282-2655 |
News Archive
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
A certain cytokine, or small protein that helps cells communicate during immune responses, can control whether immune cells promote or suppress inflammatory bowel disease, a finding that could lead to new treatments, according to a study led by Georgia State University.
Seniors with giant cell arteritis – a chronic inflammatory condition of medium and large arteries – are twice as likely to have a heart attack or stroke compared to adults without this condition, says new University of Toronto research.
Symplmed announced today that the U.S. Food and Drug Administration has accepted for review its New Drug Application (NDA) for investigational drug Prestalia, the first single-pill, fixed-dose combination (FDC) of perindopril arginine and amlodipine besylate for the treatment of hypertension in the U.S. Symplmed filed the application under section 505(b)(2) consistent with FDA's guidance.
PHT Corporation announced today the availability of the electronic version of the DHP-18 (Diabetes Health Profile) Quality of Life (QoL) questionnaire on all of its electronic patient reported outcome (ePRO) collection modalities - smartphone, tablet and Web. PHT is the global pacesetter in PRO and ePRO solutions that maximize the collection of high-quality data from clinical trial patients to improve clinical trial efficiencies.
› Verified 9 days ago
Dr. Mary Mcfaden Caldwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15000 Capital One Dr, 12078 Health Center, Richmond, VA 23238 Phone: 804-855-6000 | |
Dr. Zaroh L Neth, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Shockoe Slip, Ste 200, Richmond, VA 23219 Phone: 888-364-2334 Fax: 804-207-8833 | |
Mrs. Harriet Schanzer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6439 Iron Bridge Rd, Richmond, VA 23234 Phone: 804-271-8990 Fax: 804-271-9020 | |
William Edward Noller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4620 S Laburnum Ave, Richmond, VA 23231 Phone: 804-652-2200 Fax: 804-222-0458 | |
Angela D Middleton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Glenside Dr, Suite 110, Richmond, VA 23226 Phone: 804-288-1800 Fax: 804-288-0515 | |
Dr. Reuben Hancock Broaddus Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 511 Glendale Dr, Richmond, VA 23229 Phone: 804-740-1604 | |
Dr. Randolph Harris Palmore, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 N Hamilton St, Suite A, Richmond, VA 23221 Phone: 804-359-6880 Fax: 804-359-0611 |